文献
J-GLOBAL ID:201902247318031759
整理番号:19A0298113
去勢抵抗性前立腺癌患者のリプログラミング効果に関するドセタキセルとリバビリンの第1/2a相試験:DRREEM試験
A phase 1/2a trial of docetaxel plus ribavirin for reprogramming efficacy in patients with castration resistant prostate cancer: DRREEM trial
著者 (12件):
KOSAKA Takeo
(Keio Univ., Tokyo, JPN)
,
SHINOJIMA Toshiaki
(Keio Univ., Tokyo, JPN)
,
ABE Takayuki
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
UEDA Koji
(Cancer Precision Medicine Center)
,
KIKUCHI Kayoko
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
SAITO Yasuko
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
HAGIWARA Sachiko
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
KIKUCHI Eiji
(Keio Univ., Tokyo, JPN)
,
KOJIMA Shinichiro
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
MIYAKE Shinji
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
SAYA Hideyuki
(Keio Univ. Hospital Clinical and Translational Res. center, Tokyo, JPN)
,
OYA Mototsugu
(Keio Univ., Tokyo, JPN)
資料名:
International Journal of Urology (Web)
(International Journal of Urology (Web))
巻:
25 Suppl S1
ページ:
353
発行年:
2018年
JST資料番号:
U0707A
ISSN:
1442-2042
資料種別:
逐次刊行物 (A)
記事区分:
会議録記事
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)